These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1062034)

  • 41. [Data regarding the substantiation of MPEL of fungicides phyton (cartocide) and phyton C (cercocide) in the air of the work area].
    Gurova AI; Smoliar NIa; Drozhznina NA
    Gig Tr Prof Zabol; 1988 Oct; (10):54. PubMed ID: 3243497
    [No Abstract]   [Full Text] [Related]  

  • 42. [Toxicity tests for dental materials].
    Sato A
    Kokubyo Gakkai Zasshi; 1982 Jun; 49(2):400-6. PubMed ID: 6957507
    [No Abstract]   [Full Text] [Related]  

  • 43. [Characteristics of plasmid pBS271 controlling epsilon-caprolactam degradation by bacteria in the genus Pseudomonas].
    Boronin AM; Grishchenkov VG; Kulakov LA; Naumova RP
    Mikrobiologiia; 1986; 55(2):231-6. PubMed ID: 3724565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
    Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
    Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sensitive method of determination of caprolactam in the air].
    Ledovskikh NG
    Gig Tr Prof Zabol; 1982 Oct; (10):52-3. PubMed ID: 7173676
    [No Abstract]   [Full Text] [Related]  

  • 46. [Method of determining dimethyldioxane and caprolactam in soil].
    Marymov VI; Sergienko LI
    Gig Sanit; 1980 Mar; (3):55. PubMed ID: 7364244
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sporogenic bacteria--active destroyers of caprolactam].
    Gvozdiak PI; Roi AA; Rotmistrov MN
    Prikl Biokhim Mikrobiol; 1974; 10(5):738-40. PubMed ID: 4219046
    [No Abstract]   [Full Text] [Related]  

  • 48. [The use of a removable capron suture in the plastic repair of skull defects].
    Biriuchkov IuV; Semin AA
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (5):57-9. PubMed ID: 3063038
    [No Abstract]   [Full Text] [Related]  

  • 49. Toxilogical considerations of dental implants.
    Autian J
    Implantologist; 1976 Oct; 1(1):183-202. PubMed ID: 1076319
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: Synthesis of L-lysine. Simultaneous resolution/racemization of alpha-amino-epsilon-caprolactam.
    Sifniades S; Boyle WJ; Van Peppen JF
    J Am Chem Soc; 1976 Jun; 98(12):3738-9. PubMed ID: 1270710
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic safety studies of brotizolam in animals.
    Lehr E; Böke-Kuhn K; Danneberg P
    Arzneimittelforschung; 1986 Mar; 36(3A):532-3. PubMed ID: 3718575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and biological evaluation of caprolactam-modified bengamide analogues.
    Liu G; Ma YM; Tai WY; Xie CM; Li YL; Li J; Nan FJ
    ChemMedChem; 2008 Jan; 3(1):74-8. PubMed ID: 17994598
    [No Abstract]   [Full Text] [Related]  

  • 53. [In vitro toxicity of dental materials used in restorative and prosthetic dentistry. III. Gold and its alloys].
    Sbordone L; Police P; Ramaglia L; Russo P
    Minerva Stomatol; 1985; 34(1):103-7. PubMed ID: 3857434
    [No Abstract]   [Full Text] [Related]  

  • 54. [Toxicological and hygienic evaluation of a new, universal atmospheric corrosion inhibitor for metals, metanitrobenzene hexamethylenimine].
    Kulagina NK; Serebrianyĭ LA; Bazarova LA
    Gig Tr Prof Zabol; 1976 Jun; (6):47-8. PubMed ID: 955469
    [No Abstract]   [Full Text] [Related]  

  • 55. [Incompatibility groups of epsilon-caprolactam biodegradation plasmids from bacteria of Pseudomonas genus].
    Esikova TZ; Grishchenkov VG; Kulakov LA; Morenkova MA; Boronin AM
    Mol Gen Mikrobiol Virusol; 1990 Apr; (4):25-8. PubMed ID: 2366772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to 6-aminohexanoic acid and caprolactam.
    Subramanyam B; Callery PS; Geelhaar LA; Egorin MJ
    Xenobiotica; 1989 Jan; 19(1):33-42. PubMed ID: 2502880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 58. [Gynecologic morbidity in workers engaged in the manufacture of nitrogen fertilizers and caprolactam].
    Angelov A
    Akush Ginekol (Sofiia); 1988; 27(5):51-4. PubMed ID: 2851941
    [No Abstract]   [Full Text] [Related]  

  • 59. [Imidazopyrimidodiazepines--new heterocyclic system; synthesis and properties].
    Długosz A; Machoń Z
    Acta Pol Pharm; 1990; 47(3-4):53-7. PubMed ID: 12959244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative study on the inhibition effect of caprolactam and analogous compounds on kinins and factors of the fibrinolytic system].
    Doleschel W; Auerswald W
    Wien Med Wochenschr; 1967 Feb; 117(6):137-42. PubMed ID: 4298791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.